Literature DB >> 24206550

Colonoscopy quality assessment in a mass population screening programme based on faecal occult blood test.

Gemma Binefa, Montse García, Núria Milà, Lorena Rodríguez, Francisco Rodríguez-Moranta, Jordi Guardiola, Víctor Moreno.   

Abstract

BACKGROUND AND AIM: the success of colorectal cancer (CRC) screening programmes largely depends on the quality of the events, processes and outcomes and therefore, quality assurance of endoscopy is an essential component. The quality indicators for colonoscopy in a screening programme setting are different from those performed in symptomatic people. The objective of this study was to report the main quality indicators of colonoscopies performed after a positive faecal occult blood test (FOBT) in a CRC screening programme in Catalonia.
METHODS: the period of study includes three rounds of the CRC screening programme from June 2006 to July 2013. Two types of FOBT were used: a qualitative biochemical guaiac-based test (gFOBT) and a quantitative immunochemical test (FIT). Quality indicators analysed in this study were compared to recommended colonoscopy standards from the published guidelines.
RESULTS: during the study period, 1,806 colonoscopies were performed in 1,691 individuals with a positive FOBT. All indicators were within the standard except waiting time to colonoscopy. Caecal intubation rate was 95.6 % and adequate bowel cleansing 93.6 %. Adenoma detection rate was better using FIT than gFOBT, 30.7 and 3.8 per 1,000 screenees, respectively. Cancer detection rate was also greater using FIT. Nearly 62 % of cancers were diagnosed at an early stage. The overall complication rate was 10.7 ‰.
CONCLUSION: although the majority of results reached the recommended standards, some areas have been identified for quality enhancement. Continuous monitoring of quality indicators is essential for improving the current effectiveness of CRC screening programmes.

Entities:  

Mesh:

Year:  2013        PMID: 24206550     DOI: 10.4321/s1130-01082013000700005

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN: 1130-0108            Impact factor:   2.086


  5 in total

1.  Correlation between adenoma detection rate in colonoscopy- and fecal immunochemical testing-based colorectal cancer screening programs.

Authors:  Joaquín Cubiella; Antoni Castells; Montserrat Andreu; Luis Bujanda; Fernando Carballo; Rodrigo Jover; Ángel Lanas; Juan Diego Morillas; Dolores Salas; Enrique Quintero
Journal:  United European Gastroenterol J       Date:  2016-07-20       Impact factor: 4.623

2.  Should Assessment of Quality Indicator of Colonoscopy Be Varied Depending on the Colonoscopic Technique Level?

Authors:  Bum Su Choung; Seong Hun Kim; Kyung Bo Yoo; Seung Young Seo; In Hee Kim; Seung Ok Lee; Soo Teik Lee; Sang Wook Kim
Journal:  Dig Dis Sci       Date:  2015-11-17       Impact factor: 3.199

3.  Age- and sex-specific spatio-temporal patterns of colorectal cancer mortality in Spain (1975-2008).

Authors:  Jaione Etxeberria; María Dolores Ugarte; Tomás Goicoa; Ana F Militino
Journal:  Popul Health Metr       Date:  2014-07-10

4.  Colorectal Cancer Screening Programme in Spain: Results of Key Performance Indicators After Five Rounds (2000-2012).

Authors:  Gemma Binefa; Montse Garcia; Núria Milà; Esteve Fernández; Francisco Rodríguez-Moranta; Núria Gonzalo; Llúcia Benito; Ana Clopés; Jordi Guardiola; Víctor Moreno
Journal:  Sci Rep       Date:  2016-01-20       Impact factor: 4.379

5.  Non-coding RNA MFI2-AS1 promotes colorectal cancer cell proliferation, migration and invasion through miR-574-5p/MYCBP axis.

Authors:  Chenglong Li; Fengbo Tan; Qian Pei; Zhongyi Zhou; Yuan Zhou; Lunqiang Zhang; Dan Wang; Haiping Pei
Journal:  Cell Prolif       Date:  2019-05-16       Impact factor: 6.831

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.